Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Open Access

Engineering Escherichia coli Nissle as safe chassis for delivery of therapeutic peptides

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAarón Pantoja AnglesZAZahir AliSASherin Abdelrahman

Discussion

Loading...

Member takes

Overview

Synthetic biology enables the modulation of Escherichia coli Nissle for therapeutic peptide production, suggesting potential in cancer therapy.

Key Points

  • The engineered escherichia coli nissle chassis successfully produced therapeutic peptides for cancer applications.
  • A novel ai-based bioinformatic pipeline predicted anticancer-cell-penetrating peptide candidates, enhancing therapeutic potential.
  • By re-engineering the ecN plasmids with a crispr-cas12 system, a controllable platform for peptide delivery was developed.
  • This strategy supports advancements in microbial therapies and safe delivery mechanisms for therapeutic peptides.

Cite This Study

Angles et al. (2025) studied this question.

synapsesocial.com/papers/68bb46bd6d6d5674bccfe994https://doi.org/10.1101/2025.08.30.673081
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Construction of an engineered Escherichia coli with enhanced intestinal colonization and anti-inflammatory efficacy in colitis2025 · 1 citations
  2. 2Escherichia coli Nissle 1917 as a Probiotic Microbial Cell Factory: From Genetic Engineering to Fermentation2026 · 2 citations
  3. 3Construction of Probiotic Escherichia coli Nissle 1917 as a Next- Generation Expression Platform and Its Application in Therapeutic Protein Production2025
  4. 4Programmable Encapsulation Enables On‐Demand Proliferation of Therapeutic Bacteria for Potent Cancer Immunotherapy2026
  5. 5CRISPBac-T (CRISPR Bacteria For Targeted Therapy) the in silico platform2026